sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
22-Oct-2014 05:36
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 851-875 out of 902.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>

Public Release: 29-Nov-2012
Science
X-rays expose blueprint for possible sleeping sickness drug
Using the world's most powerful X-ray laser, scientists have exposed a possible Achilles' heel of the sleeping sickness parasite that threatens more than 60 million people in sub-Saharan Africa. The sophisticated analysis revealed the blueprint for a molecular plug that can selectively block a vital enzyme of the parasite Trypanosoma brucei. Plugging such a tailor-made molecule into the right place of the enzyme would render it inactive, thereby killing the parasite.

Contact: Thomas Zoufal
presse@desy.de
49-408-998-1666
Helmholtz Association

Public Release: 28-Nov-2012
Report finds Big Pharma is doing more for access to medicine in developing countries
The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in developing countries, finds that the industry is doing more than it was two years ago. Seventeen out of the 20 companies perform better than they did at the time of the last Index report in 2010.
Bill & Melinda Gates Foundation, Dutch Ministry of Foreign Affairs, UK Department for International Development, and others

Contact: Suzanne Wolf
swolf@atmindex.org
31-235-339-187
Access to Medicine Foundation

Public Release: 27-Nov-2012
Vaccine
Measles vaccine given with a microneedle patch could boost immunization programs
Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention.
Centers for Disease Control and Prevention, National Institutes of Health

Contact: John Toon
jtoon@gatech.edu
404-894-6986
Georgia Institute of Technology

Public Release: 27-Nov-2012
ACS Nano
New method for diagnosing malaria
Danish researchers have developed a new and sensitive method that makes it possible to diagnose malaria from a single drop of blood or saliva. The method might eventually be used in low-resource areas without the need for specially trained personnel, expensive equipment, clean water or electricity. With the development of this method, the researchers hope to go one step further in identifying and treating all patients suffering from malaria.

Contact: Birgitta R. Knudsen
brk@mb.au.dk
45-60-20-26-73
Aarhus University

Public Release: 27-Nov-2012
Evolution, Medicine and Public Health
Malaria study suggests drugs should target female parasites
Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease.
Wellcome Trust

Contact: Eleanor Cowie
eleanor.cowie@ed.ac.uk
44-131-650-6382
University of Glasgow

Public Release: 22-Nov-2012
Antimicrobial Agents and Chemotherapy
'Repurposed' anti-parasite drug shows promise as new TB treatment: UBC research
A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis, according to new research from University of British Columbia microbiologists. The findings, published online this week in the journal Antimicrobial Agents and Chemotherapy, are based on in vitro tests of the avermectin family of drugs. Discovered nearly 40 years ago, the drugs are commonly used in the developing world to eliminate the parasitic worms that cause river blindness and elephantiasis.
Canadian Institute of Health Research, British Columbia Lung Association, Grand Challenges Canada

Contact: Chris Balma
balma@science.ubc.ca
604-822-5082
University of British Columbia

Public Release: 22-Nov-2012
Antimicrobial Agents and Chemotherapy
'Repurposed' anti-parasite drug shows promise as new TB treatment: UBC research
A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis, according to new research from University of British Columbia microbiologists.

Contact: Chris Balma
balma@science.ubc.ca
604-822-5082
University of British Columbia

Public Release: 22-Nov-2012
Science
Study reveals the proteins expressed by human cytomegalovirus
New findings reveal the surprisingly complex protein-coding capacity of the human cytomegalovirus and provide the first steps toward understanding how the virus manipulates human cells during infection. The related study appears in the Nov. 23 issue of the journal Science, which is published by AAAS, the nonprofit science society.

Contact: Natasha Pinol
npinol@aaas.org
202-326-6440
American Association for the Advancement of Science

Public Release: 22-Nov-2012
Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries
Some 51 innovators in 18 low and middle income countries and 17 in Canada will share $7 million in Canadian grants to pursue bold, creative ideas for tackling health problems in resource-poor parts of the world. The projects will be implemented worldwide: 38 in Africa, 23 in Asia, five in Latin America/Caribbean, and two in the Middle East
Grand Challenges Canada

Contact: Terry Collins
tc@tca.tc
416-538-8712
Sandra Rotman Centre for Global Health

Public Release: 19-Nov-2012
UBC professor wins Canada's top pharmaceutical research award
University of British Columbia microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honor in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unraveling the complex interactions between antibiotics and bacteria.
Innovation Life Canada

Contact: Silvia Moreno-Garcia
silvia.moreno-garcia@science.ubc.ca
604-822-5001
University of British Columbia

Public Release: 19-Nov-2012
ACS Nano
Rice unveils super-efficient solar-energy technology
Rice University scientists have unveiled a revolutionary new technology that uses nanoparticles to convert solar energy directly into steam. The new "solar steam" method from Rice's Laboratory for Nanophotonics is so effective it can even produce steam from icy cold water. Details of the solar steam method were published online today in ACS Nano. The technology's inventors said they expect it will first be used in sanitation and water-purification applications in the developing world.
Welch Foundation, Bill and Melinda Gates Foundation

Contact: Mike Williams
mikewilliams@rice.edu
713-348-6728
Rice University

Public Release: 19-Nov-2012
NIH awards Georgia malaria research consortium up to $19.4 million contract
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year contract of up to $19.4 million, depending on contract options exercised, to establish the Malaria Host-Pathogen Interaction Center (MaHPIC). The consortium includes researchers at Emory University, with partners at the University of Georgia (UGA), the Georgia Institute of Technology (Georgia Tech) and the Centers for Disease Control and Prevention (CDC). The Yerkes National Primate Research Center of Emory University will administer the contract.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 16-Nov-2012
GW Researcher receives grant to study parasitic worm role in bile duct cancer in Southeast Asia
Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, was the recipient of a $1.7 million grant from the National Cancer Institute to study the behavior of a parasitic worm, rampant in Southeast Asia, known to cause infections that contribute to liver cancer.
NIH/National Cancer Institute

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 15-Nov-2012
World Health Organisation’s Framework Convention on Tobacco Control
Tobacco Control
Cash cuts increase smoking death risk for world's poor, study says
Proposed funding cuts within the international body responsible for tobacco control will leave the world's poorest countries more vulnerable to smoking-related diseases, a study suggests.

Contact: Edd McCracken
edd.mccracken@ed.ac.uk
44-013-165-14400
University of Edinburgh

Public Release: 14-Nov-2012
Genes & Development
How cells in the nose detect odors
A team of scientists, led by neurobiologists at the University of California, Riverside, has studied the olfactory receptor for detecting carbon dioxide in Drosophila, and identified a large multi-protein complex in olfactory neurons, called MMB/dREAM, that plays a major role in selecting the carbon dioxide receptors to be expressed in appropriate neurons.
Whitehall Foundation

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 14-Nov-2012
New England Journal of Medicine
Possible link between immune system and Alzheimer's
An international research team including scientists from the University of Toronto's Faculty of Medicine has discovered a link between a mutation in an immune system gene and Alzheimer's disease.

Contact: Nicole Bodnar
nicole.bodnar@utoronto.ca
416-978-5811
University of Toronto

Public Release: 14-Nov-2012
Cell Host & Microbe
Tolerance to malaria by means of iron control
In a study published in the latest issue of Cell Host & Microbe, scientists at Instituto Gulbenkian de Ciencia, Portugal, discovered that the development of severe malaria can be prevented by a mechanism that controls the accumulation of iron in tissues of the infected host. Expression of a gene that neutralizes iron inside cells, named H-Ferritin, reduces oxidative stress preventing tissue damage and death. This protective mechanism provides a new therapeutic strategy against malaria.
Fundação para a Ciência e a Tecnologia, and others

Contact: Ana Mena
anamena@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia

Public Release: 14-Nov-2012
PLOS ONE
The hidden consequences of helping rural communities in Africa
Improving water supplies in rural African villages may have negative knock-on effects and contribute to increased poverty, new research published today [Nov. 14] has found. Rural development initiatives across the developing world are designed to improve community wellbeing and livelihoods but a study of Ethiopian villages by researchers at the Universities of Bristol and Addis Ababa in Africa has shown that this can lead to unforeseen consequences caused by an increase in the birth rate in the absence of family planning.
Leverhulme Trust

Contact: Philippa Walker
philippa.walker@bristol.ac.uk
01-179-287-777
University of Bristol

Public Release: 14-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
Meningitis A vaccine breaks barrier; first to gain approval to travel outside cold chain
Signaling a potential breakthrough for immunization programs in resource-poor countries, researchers today announced at the American Society of Tropical Medicine and Hygiene conference that regulatory authorities--after conducting a rigorous review of stability data--will for the first time allow a vaccine in Africa to be transported and stored for as long as four days without refrigeration or even an icepack.

Contact: Coimbra Sirica
CSirica@burnesscommunications.com
301-943-3287
Burness Communications

Public Release: 13-Nov-2012
Science
Scientists question the designation of some emerging diseases
The Ebola, Marburg and Lassa viruses are commonly referred to as emerging diseases, but leading scientists say these life-threatening viruses have been around for centuries.

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 13-Nov-2012
Second most common infection in the US proving harder to treat with current antibiotics
Certain types of bacteria responsible for causing urinary tract infections, the second-most-common infection in the US, are becoming more difficult to treat with current antibiotics, according to new research from Extending the Cure (ETC), a project of the Center for Disease Dynamics, Economics & Policy. ETC released the research via its online ResistanceMap, an online tool created to track changes in antibiotic drug use and resistance, which features analysis using ETC's Drug Resistance Index.
Center for Disease Dynamics, Economics & Policy

Contact: Dionne Dougall-Bass
dionne@burnesscommunications.com
301-961-5803
Burness Communications

Public Release: 13-Nov-2012
Open access initiative reveals drug hits for deadly neglected tropical diseases
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases, through DNDi's screening of MMV's open access Malaria Box. The resulting DNDi screening data are among the first data generated on the Malaria Box to be released into the public domain, exemplifying the potential of openly sharing drug development data for neglected patients.

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 13-Nov-2012
PLOS Medicine
Common enzyme deficiency may hinder plans to eradicate malaria
In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria, according to a study funded by the Wellcome Trust and published in this week's PLOS Medicine.

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
PLOS

Public Release: 13-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
American Journal of Tropical Medicine and Hygiene
Scientists report injectable formulation of malaria parasites achieve controlled infection
In a breakthrough that could accelerate malaria vaccine and drug development, scientists announced today that, for the first time ever, human volunteers were infected with malaria via a simple injection of cryopreserved sterile parasites that were harvested from the salivary glands of infected mosquitoes in compliance with regulatory standards. The parasites had been frozen in a vial for more than two years.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 13-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
Experts report 1 of 2 remaining types of polio virus may be eliminated in Pakistan
Polio cases worldwide reached historic lows in 2012, and for the first time there were no new outbreaks beyond countries already harboring the disease, leaving researchers confident that a massive and re-energized international campaign to eradicate polio is on a path to success, according to presentations today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Showing releases 851-875 out of 902.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>